NYSE:ZTSPharmaceuticals
Is Zoetis (ZTS) Now An Opportunity After A 31% Five Year Share Price Drop
If you have been wondering whether Zoetis at around US$113.83 is starting to look attractively priced, you are not alone.
The stock has seen a 3.1% decline over the last week, a 2.1% decline over the last month, and is down 9.6% year to date, adding to a 26.1% decline over 1 year and 33.6% over 3 years.
These moves have come as investors reassess large pharmaceutical and animal health names in general, with sentiment shifting after changing expectations around growth and regulation. For...